APOB and familial hypercholesterolemia: A randomized, double-blind, placebo-controlled trial involving nine individuals with hypercholesterolemia and hypertriglyceridemia investigated the influence of different doses of atorvastatin on human ApoB100 kinetics in triglyceride-rich lipoprotein (TRL), IDL, and LDL.